EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Cell factory engineering: Challenges and opportunities for synthetic biology applications

Bhagyashree Bachhav, Jacopo de Rossi, Carlos D Llanos, Laura Segatori iD

Biotechnology and Bioengineering · 2023-09 · 120 (9) · 2441-2459

DOI: 10.1002/bit.28365 ↗

At a glance

Übersichtsarbeit in Biotechnology and Bioengineering, 2023-09. Written by Bhagyashree Bachhav and 3 co-authors. Institution: Department of Chemical and Biochemical Engineering, Rice University, Houston, Texas, USA. Major MEDLINE topics: Synthetic Biology, Cell Engineering. Cited 29 times so far (Crossref); 152 references. The full text is freely available in PubMed Central. Funded by: NIBIB NIH HHS, NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The production of high‐quality recombinant proteins is critical to maintaining a continuous supply of biopharmaceuticals, such as therapeutic antibodies. Engineering mammalian cell factories presents a number of limitations typically associated with the proteotoxic stress induced upon aberrant accumulation of off‐pathway protein folding intermediates, which eventually culminate in the induction of apoptosis. In this review, we will discuss advances in cell engineering and their applications at different hierarchical levels of control of the expression of recombinant proteins, from transcription and translational to posttranslational modifications and subcellular trafficking. We also highlight challenges and unique opportunities to apply modern synthetic biology tools to the design of programmable cell factories for improved biomanufacturing of therapeutic proteins.

Subjects

MeSH terms (MEDLINE)

Synthetic BiologyCell EngineeringAnimalsRecombinant ProteinsProtein Processing, Post-TranslationalMetabolic EngineeringMammals

Author keywords

cell engineeringgenetic engineeringmammalian cell factoriesmammalian synthetic biologyrecombinant proteins

Substances

Recombinant Proteins

Authors and institutions

  • Department of Chemical and Biochemical Engineering, Rice University, Houston, Texas, USA.
  • Systems, Synthetic, and Physical Biology, Rice University, Houston, Texas, USA.
  • Department of Bioengineering, Rice University, Houston, Texas, USA.
  • Department of Biosciences, Rice University, Houston, Texas, USA.

ORCID profiles: Laura Segatori

Funding

  • NIBIB NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Bachhav, B., de Rossi, J., Llanos, C. D., & Segatori, L. (2023). Cell factory engineering: Challenges and opportunities for synthetic biology applications. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28365

Vancouver

Bachhav B, de Rossi J, Llanos CD, Segatori L. Cell factory engineering: Challenges and opportunities for synthetic biology applications. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28365

BibTeX
@article{Bachhav2023,
  author = {Bachhav, Bhagyashree and de Rossi, Jacopo and Llanos, Carlos D and Segatori, Laura},
  title = {Cell factory engineering: Challenges and opportunities for synthetic biology applications},
  journal = {Biotechnology and Bioengineering},
  year = {2023},
  doi = {10.1002/bit.28365}
}
Start for free →